Spinal Morphine for Postoperative Analgesia in Urology
Comparison of Spinal Morphine With Systemic Analgesia After Urologic Surgery
1 other identifier
interventional
98
1 country
1
Brief Summary
The study was performed in urology patients elicited for open prostatectomy or open nephrectomy. Comparison of analgesic effect between group (M) with spinal morphine before general anaesthesia and group without this intervention was measured.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Mar 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 5, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 10, 2017
CompletedFirst Submitted
Initial submission to the registry
August 23, 2018
CompletedFirst Posted
Study publicly available on registry
September 18, 2018
CompletedSeptember 19, 2018
September 1, 2018
1.3 years
August 23, 2018
September 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Duration of analgesia
Time to the first morphine request during the first two days of ICU stay after surgery (in hours) and total morphine consumption during the first two days of ICU stay (in mg)
48 hours
Secondary Outcomes (1)
Morphine side effects
48 hours
Study Arms (2)
Morphine group M
EXPERIMENTALExperimental group M were administered preservative-free morphine 250 mcg in 2.5 ml NS intrathecal using 25 G needle in L1/2 - L5/S1 interspaces.
Control group C
NO INTERVENTIONNo intervention
Interventions
Intrathecal injection of 250 mcg preservative-free morphine before surgery
Eligibility Criteria
You may qualify if:
- elicited open prostatectomy or open nephrectomy
You may not qualify if:
- drug or alcohol dependence
- psychiatric drug use
- ASA classification IV or V
- general contraindication to neuroaxial injection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Kralovske Vinohrady
Prague, 100 00, Czechia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jiri Malek, M.D.
3rd Medical Faculty, Charles University
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Only ICU personnel was blinded to the method used
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof., M.D., Ph.D.
Study Record Dates
First Submitted
August 23, 2018
First Posted
September 18, 2018
Study Start
March 5, 2016
Primary Completion
June 30, 2017
Study Completion
July 10, 2017
Last Updated
September 19, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share